Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $25.88 million. The enterprise value is $24.82 million.

Market Cap	25.88M
Enterprise Value	24.82M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

AKTX has 32.61 million shares outstanding. The number of shares has increased by 235.61% in one year.

Current Share Class	n/a
Shares Outstanding	32.61M
Shares Change (YoY)	+235.61%
Shares Change (QoQ)	+15.31%
Owned by Insiders (%)	80.38%
Owned by Institutions (%)	1.69%
Float	5.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.96
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.19, with a Debt / Equity ratio of 0.06.

Current Ratio	0.19
Quick Ratio	0.16
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.92

Financial Efficiency

Return on equity (ROE) is -112.02% and return on invested capital (ROIC) is -65.40%.

Return on Equity (ROE)	-112.02%
Return on Assets (ROA)	-28.56%
Return on Invested Capital (ROIC)	-65.40%
Return on Capital Employed (ROCE)	-37.87%
Revenue Per Employee	n/a
Profits Per Employee	-$1.36M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.83% in the last 52 weeks. The beta is 0.27, so AKTX's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-74.83%
50-Day Moving Average	0.96
200-Day Moving Average	1.13
Relative Strength Index (RSI)	46.37
Average Volume (20 Days)	256,580

Short Selling Information

Short Interest	24,554
Short Previous Month	76,916
Short % of Shares Out	0.12%
Short % of Float	n/a
Short Ratio (days to cover)	0.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.79M
Pretax Income	n/a
Net Income	-12.27M
EBITDA	-12.78M
EBIT	-12.79M
Earnings Per Share (EPS)	-$0.54

Balance Sheet

The company has $2.71 million in cash and $1.55 million in debt, giving a net cash position of $1.16 million or $0.04 per share.

Cash & Cash Equivalents	2.71M
Total Debt	1.55M
Net Cash	1.16M
Net Cash Per Share	$0.04
Equity (Book Value)	25.61M
Book Value Per Share	0.79
Working Capital	-13.84M

Cash Flow

Operating Cash Flow	-9.02M
Capital Expenditures	n/a
Free Cash Flow	-9.02M
FCF Per Share	-$0.28

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-235.61%
Shareholder Yield	-235.61%
Earnings Yield	-47.21%
FCF Yield	-34.71%

Analyst Forecast

The average price target for AKTX is $3.30, which is 315.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.30
Price Target Difference	315.83%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 17, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 17, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1